ViCardia is a clinical-stage biopharmaceutical company.
ViCardia has raised $700K in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in May 2026.
ViCardia is headquartered in San Francisco, United States.
ViCardia is a clinical-stage biopharmaceutical company.
ViCardia is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"ViCardia — Funding & Investors." VCBacked, May 21, 2026, https://www.vcbacked.co/company/vicardia. Accessed August 13, 2026.
VCBacked. (2026). ViCardia — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/vicardia
{{cite web |title=ViCardia — Funding & Investors |url=https://www.vcbacked.co/company/vicardia |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated